# Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies

> **NCT06508775** · NA · RECRUITING · sponsor: **Miltenyi Biomedicine GmbH** · enrollment: 40 (estimated)

## Conditions studied

- Melanoma Stage III
- B-cell Non Hodgkin Lymphoma
- Pediatric ALL
- Childhood Non-Hodgkin Lymphoma
- Acute Lymphatic Leukemia
- Chronic Lymphatic Leukemia
- Melanoma Stage IV

## Interventions

- **BIOLOGICAL:** MB-CART19.1
- **BIOLOGICAL:** MB-CART20.1
- **BIOLOGICAL:** MB-CART2019.1

## Key facts

- **NCT ID:** NCT06508775
- **Lead sponsor:** Miltenyi Biomedicine GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-05
- **Primary completion:** 2040-12-31
- **Final completion:** 2040-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06508775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06508775, "Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06508775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*